glp-1 obesity drug news october 2025 The world is desperate for weight-loss drugs. But Big Pharma can't advertise them Obesity GLP-1 Market Size to

It boosts immune function and aids collagen synthesis while improving iron absorption

While rare, these require immediate medical attention

Clinical trials show superior weight loss outcomes compared to tirzepatide alone, though the combination significantly increases gastrointestinal side effects like nausea and vomiting

Incretin hormones and type 2 diabetes In people without T2D, GIP is the dominant incretin hormone, having a greater insulotropic effect than GLP-1 (Nauck and Meier, 2016)

"The details were limited, but the results suggested there may be some promise in improving overall pain scores." These newer peptides have some studies, but most are in animal models, not humans, to determine how it would act in the human body